The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterizing the landscape of RING-type E3 ubiquitin transferase-altered (RNF43 alt) colorectal cancer (CRC) and defining unique subsets with potential therapeutic vulnerabilities in microsatellite instability-high (MSI-H) CRC.
 
Abdul Rafeh Naqash
No Relationships to Disclose
 
Amin Nassar
No Relationships to Disclose
 
Lisa Macera
Employment - Exact Sciences; Tempus
Stock and Other Ownership Interests - Agilent; AstraZeneca; Exact Sciences
 
Elizabeth Mauer
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Research Funding - Tempus
Travel, Accommodations, Expenses - Tempus
 
Justin Guinney
Employment - Tempus
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); Bristol Meyers Squib (Inst); Roche/Genentech (Inst)
 
Calvin Y. Chao
Employment - Exact Sciences; Tempus
Leadership - Exact Sciences; Tempus
Stock and Other Ownership Interests - Exact Sciences; Tempus
 
Elio Adib
Employment - Amgen (I)
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Ceres Nanosciences; Perthera; Theralink
Consulting or Advisory Role - Ceres Nanosciences; Perthera; Theralink
Research Funding - Ceres Nanosciences (Inst); Deciphera; G1 Therapeutics (Inst); Genentech (Inst); Mirati Therapeutics (Inst); SpringWorks Therapeutics
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera
 
Arjun Mittra
Stock and Other Ownership Interests - Merck (I)
 
Naoko Takebe
No Relationships to Disclose
 
Timothy Lewis Cannon
Honoraria - AstraZeneca; Bayer; Deciphera
Consulting or Advisory Role - Intermountain Healthcare
Other Relationship - Navican/ Intermountain Healthcare